Letters
Deprescribing
Should we deprescribe the term “deprescribing”?
BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q2007 (Published 13 September 2024) Cite this as: BMJ 2024;386:q2007
- Lisa Kouladjian O’Donnell, lecturer and clinical pharmacist,
- Aili Langford, lecturer, clinical pharmacist, and National Health and Medical Research Council emerging leader fellow
- School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
- lisa.kouladjian{at}sydney.edu.au
We were surprised to read that the term “deprescribing” raises concerns for Zermansky.1 We counter that deprescribing—both the term and the concept—serve an important and specific function in achieving person centred drug management.
Deprescribing is “the process of withdrawal of an inappropriate medication, supervised by healthcare professionals with the goal of managing polypharmacy and improving outcomes.”2 This definition places patients and their drug …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.